DHR vs VRT: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Vertiv Holdings Co · Industrials
$305.14
-19.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
VRT |
| Current Price |
$174.04 |
$305.14 |
| Fair Value Estimate |
$197.01 |
$246.77 |
| Upside to Fair Value |
+13.2%
|
-19.1%
|
| Market Cap |
$123.2B |
$116.8B |
| Forward P/E |
33.4x
|
75.0x
|
| EV / EBITDA |
20.3x
|
50.1x
|
| Price / Sales |
5.0x
|
10.8x
|
| Price / FCF |
23.3x
|
50.5x
|
| Revenue Growth YoY |
+3.7%
|
+30.1%
|
| Gross Margin |
60.7%
|
36.2%
|
| Operating Margin |
21.0%
|
18.5%
|
| Return on Equity |
7.1%
|
42.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
1.98%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Vertiv Holdings Co operates in the electrical equipment and parts industry within the industrials sector, focusing on critical digital infrastructure technology products and services. The company has demonstrated strong business quality with a 42.1% return on equity, 30.1% revenue growth, and 137.1% earnings growth in the most recent quarter, supported by solid margins including a 36.2% gross mar…
Accumulation Zones
| Metric |
DHR |
VRT |
| Zone Low |
$147.76 |
$185.08 |
| Zone High |
$167.46 |
$209.75 |
| In Buy Zone? |
No
|
No
|